IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Celator Pharmaceuticals
Symbol: CPXX
Price: Last trade $10.01
Trade Date: 3/23
Shares: 3 million
Underwriter(s) Stifel, Needham & Co.
Co Manager(s) Roth Capital Partners, H.C. Wainwright, National Securities
Rating=Subscription Needed
Company: Sun Communities, Inc.
Symbol: SUI
Price: Last trade $68.36
Trade Date: 3/24
Shares: 4 million
Underwriter(s) BofA Merrill Lynch, Citigroup
Rating=Subscription Needed
Company: Shell Midstream Partners, L.P.
Symbol: SHLX
Price: Last trade $34.03
Trade Date: 3/23
Shares: 8.5 million
Underwriter(s) Barclays
Rating=Subscription Needed
Company: The Michaels Companies, Inc.-BLOCK
Symbol: MIK
Price: Last trade $26.93
Trade Date: 3/23
Shares: 17 million
Underwriter(s) J.P. Morgan, BofA Merrill Lynch
Rating=Subscription Needed